サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1763150

自動免疫測定装置の世界市場

Automated Immunoassay Analyzers

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.66円
自動免疫測定装置の世界市場
出版日: 2025年07月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

自動免疫測定装置の世界市場は2030年までに47億米ドルに達する見込み

2024年に36億米ドルと推定される自動免疫測定装置の世界市場は、2024年から2030年にかけてCAGR 4.5%で成長し、2030年には47億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである免疫蛍光は、CAGR 4.7%を記録し、分析期間終了までに12億米ドルに達すると予測されます。化学発光免疫測定（CLIA）分野の成長率は、分析期間のCAGRで4.3％と推定されます。

米国市場は推定9億9,330万米ドル、中国はCAGR4.4％で成長予測

米国の自動免疫測定装置市場は、2024年に9億9,330万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに7億5,440万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは4.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.2%と3.7%と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界の自動免疫測定装置市場- 主要動向と促進要因のまとめ

現代の診断に自動免疫測定装置が欠かせない理由とは？

自動免疫測定装置は、生物学的サンプルの迅速で正確なハイスループット検査を可能にすることで、診断ラボに革命をもたらしています。これらの機器は、血液やその他の液体に含まれる特定のタンパク質、ホルモン、抗体を検出し、定量化するために極めて重要であり、感染症診断、腫瘍学、内分泌学などの分野で不可欠なものとなっています。医療制度が早期発見と個別化医療を優先する中、イムノアッセイはHIV、がん、糖尿病などの診断に不可欠なツールとなっています。これらの検査の自動化は、人為的ミスのリスクを低減するだけでなく、診断ラボの効率を高め、手作業を最小限に抑えながら大量のサンプルを処理することを可能にします。診断検査の需要が世界的に高まる中、自動免疫測定装置は現代のヘルスケアに不可欠なものとなりつつあります。

技術の進歩は自動免疫測定装置をどのように強化していますか？

技術革新は自動免疫測定装置の能力と精度を著しく向上させています。化学発光や蛍光などの検出方法の進歩により、感度と特異性が向上し、バイオマーカーをより早く、より正確に検出できるようになりました。さらに、人工知能（AI）や機械学習アルゴリズムをこれらのシステムに統合することで、複雑なデータの解析や解釈を最適化し、臨床医がより多くの情報に基づいた診断判断を下せるよう支援しています。自動化はサンプル調製やデータ管理にも及んでおり、ワークフローをさらに合理化し、結果に要する時間を短縮しています。ラボがターンアラウンドタイムと業務効率の改善を求める中、こうした技術的進歩が自動免疫測定装置の普及を後押ししています。

自動免疫測定装置の使用は、どのような規制やコンプライアンス基準で管理されていますか？

自動免疫測定装置市場では、診断検査の正確性と信頼性が患者の治療に直接影響するため、規制当局の監視が非常に重要です。FDAや欧州医薬品庁（EMA）などの機関は、免疫測定分析装置が市場に導入される前に、安全性と有効性の基準を満たしていることを保証するために、厳しいガイドラインを実施しています。これらの規制により、メーカーは厳格な臨床試験を実施し、製造中の品質管理を維持することが求められます。さらに、医療検査室の能力を規定するISO 15189のような国際規格への準拠は、これらのシステムを使用する検査室にとって、検査結果が正確で信頼できるものであることを保証するために不可欠です。特に北米や欧州のような規制の厳しい地域では、こうした規制の枠組みを遵守することが市場拡大には必要です。

自動免疫測定装置市場の成長を促進する要因は？

自動免疫測定装置市場の成長は、診断検査に対する需要の高まり、慢性疾患の有病率の増加、検査効率と精度を向上させる技術の進歩など、いくつかの要因によってもたらされます。感染症やがん、糖尿病などの疾患の罹患率の増加が、免疫測定が中心的な役割を果たすより高度な診断ツールの必要性を高めています。正確なバイオマーカー検出を必要とする個別化医療の動向は、これらの分析装置の需要をさらに押し上げています。さらに、自動化とAI統合の進歩によりラボの生産性が向上し、ヘルスケア施設が品質を維持しながらより多くの検査量を処理できるようになっています。最後に、ヘルスケアインフラの改善に後押しされた新興市場における診断検査の拡大が、新たな成長機会を生み出しています。

セグメント

最終用途（病院、診断ラボ、血液銀行、その他の最終用途）、技術（免疫蛍光、化学発光免疫測定法（CLIA）、酵素結合蛍光免疫測定法（ELFA）、酵素結合免疫吸着測定法（ELISA）、ラジオイムノアッセイ（RIA）、その他の技術）

調査対象企業の例

  • Artron Laboratories, Inc.
  • Awareness Technology, Inc.
  • Beckman Coulter（UK）Ltd.
  • Chengdu Empsun Medical Co., Ltd.
  • Diagnostic Automation/Cortez Diagnostics, Inc.
  • DiaSorin SpA
  • DRG Instruments GmbH
  • Erba Mannheim
  • Guangzhou Wondfo Biotech Co., Ltd
  • H&W Biotech Oy

AIインテグレーション

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16161

Global Automated Immunoassay Analyzers Market to Reach US$4.7 Billion by 2030

The global market for Automated Immunoassay Analyzers estimated at US$3.6 Billion in the year 2024, is expected to reach US$4.7 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Immunofluorescence, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Chemiluminescence Immunoassay (CLIA) segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$993.3 Million While China is Forecast to Grow at 4.4% CAGR

The Automated Immunoassay Analyzers market in the U.S. is estimated at US$993.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$754.4 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Automated Immunoassay Analyzers Market - Key Trends & Drivers Summarized

Why Are Automated Immunoassay Analyzers Vital for Modern Diagnostics?

Automated immunoassay analyzers are revolutionizing diagnostic laboratories by enabling rapid, accurate, and high-throughput testing of biological samples. These instruments are crucial for detecting and quantifying specific proteins, hormones, and antibodies in blood or other fluids, making them essential in areas such as infectious disease diagnostics, oncology, and endocrinology. As healthcare systems prioritize early detection and personalized medicine, immunoassays have become a critical tool for diagnosing conditions such as HIV, cancer, and diabetes. The automation of these tests not only reduces the risk of human error but also increases the efficiency of diagnostic labs, enabling them to process large volumes of samples with minimal manual intervention. As the demand for diagnostic testing grows globally, automated immunoassay analyzers are becoming integral to modern healthcare.

How Are Technological Advancements Enhancing Automated Immunoassay Analyzers?

Technological innovations are significantly improving the capabilities and accuracy of automated immunoassay analyzers. Enhanced sensitivity and specificity, driven by advancements in detection methods such as chemiluminescence and fluorescence, are enabling earlier and more precise detection of biomarkers. Moreover, the integration of artificial intelligence (AI) and machine learning algorithms into these systems is optimizing the analysis and interpretation of complex data, helping clinicians make more informed diagnostic decisions. Automation is also extending to sample preparation and data management, further streamlining workflows and reducing the time required for results. As labs seek to improve turnaround times and operational efficiency, these technological advancements are driving the widespread adoption of automated immunoassay analyzers.

What Regulatory and Compliance Standards Govern the Use of Automated Immunoassay Analyzers?

Regulatory oversight is critical in the automated immunoassay analyzers market, as the accuracy and reliability of diagnostic tests directly impact patient care. Agencies such as the FDA and European Medicines Agency (EMA) enforce strict guidelines to ensure that immunoassay analyzers meet safety and efficacy standards before they are introduced to the market. These regulations require manufacturers to conduct rigorous clinical trials and maintain quality control during production. Additionally, compliance with international standards such as ISO 15189, which governs the competence of medical laboratories, is essential for labs using these systems to ensure that their test results are accurate and reliable. Adherence to these regulatory frameworks is necessary for market expansion, especially in highly regulated regions such as North America and Europe.

What Factors Are Driving the Growth of the Automated Immunoassay Analyzers Market?

The growth in the automated immunoassay analyzers market is driven by several factors, including the rising demand for diagnostic testing, the increasing prevalence of chronic diseases, and technological advancements that improve testing efficiency and accuracy. The growing incidence of infectious diseases and conditions such as cancer and diabetes is driving the need for more sophisticated diagnostic tools, where immunoassays play a central role. The trend toward personalized medicine, which requires precise biomarker detection, is further boosting demand for these analyzers. Additionally, advancements in automation and AI integration are enhancing lab productivity, allowing healthcare facilities to handle higher test volumes while maintaining quality. Finally, the expansion of diagnostic testing in emerging markets, fueled by improvements in healthcare infrastructure, is creating new opportunities for growth.

SCOPE OF STUDY:

The report analyzes the Automated Immunoassay Analyzers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

End-Use (Hospitals, Diagnostic Laboratories, Blood Bank, Other End-Uses); Technology (Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Other Technologies)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 41 Featured) -

  • Artron Laboratories, Inc.
  • Awareness Technology, Inc.
  • Beckman Coulter (UK) Ltd.
  • Chengdu Empsun Medical Co., Ltd.
  • Diagnostic Automation / Cortez Diagnostics, Inc.
  • DiaSorin SpA
  • DRG Instruments GmbH
  • Erba Mannheim
  • Guangzhou Wondfo Biotech Co., Ltd
  • H&W Biotech Oy

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Automated Immunoassay Analyzers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Chronic Diseases Driving Adoption of Immunoassay Analyzers
    • Technological Advancements in Automated Analyzers Boosting Market Growth
    • Growing Focus on Early Disease Detection Supporting Demand for Immunoassay Solutions
    • Rising Adoption in Clinical Laboratories for High-Throughput Testing Fuelling Growth
    • Expansion of Point-of-Care Diagnostics Enhancing Immunoassay Analyzer Market Demand
    • Increasing Healthcare Spending in Emerging Economies Boosting Market Opportunities
    • Rising Awareness of Personalized Medicine Supporting Use of Advanced Immunoassays
    • Growth of Infectious Disease Testing Requirements Supporting Analyzer Adoption
    • Development of Multiplex Testing Platforms Fuelling Innovations in Immunoassay Analyzers
    • Stringent Regulatory Standards for Laboratory Testing Supporting Automated Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Automated Immunoassay Analyzers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Automated Immunoassay Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Automated Immunoassay Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Immunofluorescence by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Immunofluorescence by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay (CLIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Chemiluminescence Immunoassay (CLIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Chemiluminescence Immunoassay (CLIA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Enzyme Linked Fluorescent Immunoassay (ELFA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Enzyme Linked Immunosorbent Assay (ELISA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Radioimmunoassay (RIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Radioimmunoassay (RIA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Radioimmunoassay (RIA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Blood Bank by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Blood Bank by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Blood Bank by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Japan 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 53: China Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: China 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Automated Immunoassay Analyzers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Automated Immunoassay Analyzers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Europe 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 71: France Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: France Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: France 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 77: Germany Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Germany Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Germany 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 83: Italy Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Italy Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Italy 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 86: UK Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 89: UK Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: UK Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: UK 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Automated Immunoassay Analyzers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Automated Immunoassay Analyzers by Technology - Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Automated Immunoassay Analyzers by Technology - Percentage Breakdown of Value Sales for Immunofluorescence, Chemiluminescence Immunoassay (CLIA), Enzyme Linked Fluorescent Immunoassay (ELFA), Enzyme Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA) and Other Technologies for the Years 2015, 2025 & 2030
    • TABLE 107: Rest of World Recent Past, Current & Future Analysis for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of World Historic Review for Automated Immunoassay Analyzers by End-Use - Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of World 15-Year Perspective for Automated Immunoassay Analyzers by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Blood Bank and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION